NFKB1 and inflammatory bowel disease: Abnormal activation of NF‐κB signalling plays the pivotal role in inflammatory diseases such as asthma, rheumatoid arthritis and inflammatory bowel disease so that the antagonization of NF‐κB signalling can be an effective therapeutic strategy for inflammatory diseases.54